医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

巴塞罗那“中期”肝细胞癌各亚组患者肝切除术预后的比较

Comparison of the prognosis after hepatic resection for patients with Barcelona Clinical Liver Cancer Stage B hepatocellular carcinoma

摘要目的 比较接受肝切除术治疗的巴塞罗那“中期”肝细胞癌各亚组患者的总生存率,并研究疗效随时间的变化情况.方法 连续性选取初次治疗方式为肝切除术的巴塞罗那中期肝细胞癌患者918例,分为3组:甲组:单个肿瘤且肿瘤直径≥5 cm,582例;乙组:2~3个肿瘤且最大直径>3 cm,223例;丙组:3个以上肿瘤,n=113.比较3组患者在2001-2007年和2008-2013年的住院死亡率和总生存率.结果 丙组患者的住院死亡率显著高于另外两组(P<0.05),但丙组患者的1、3、5年总生存率显著低于乙组患者(P<0.05),而乙组患者又显著低于甲组患者(P<0.05).甲、乙和丙3组患者的中位生存时间分别为47.3、36.9、和23.5个月.甲组和丙组患者在2008-2013年的总生存率显著优于2001-2007年(P<0.05),但乙组患者在2008-2013年的总生存率仅稍优于2001-2007年(P=0.084).结论 3组患者的预后明显不同,肿瘤数量>3的肝细胞癌患者行肝切除术后的住院死亡率最高而总生存率最低;随着手术技巧和围手术期护理技术的不断提高,肝切除术后肝细胞癌患者总生存率在不断提高.

更多

abstractsObjective To compare the efficacy of hepatic resection (HR) in patients with Barcelona Clinical Liver Cancer (BCLC) Stage B hepatocellular carcinoma (HCC) and examine how that efficacy has changed over time in a large medical center.Methods A consecutive sample of 918 patients with preserved liver function and large and/or multinodular HCC who were treated by initial HR were divided into three groups:those with a single tumor ≥5 cm in diameter (n =582),2-3 tumors with a maximum diameter > 3 cm (n =223),or > 3 tumors of any diameter (n =113).Hospital mortality and overall survival (OS) in each group were compared for the years 2001-2007 and 2008-2013.Results Patients with > 3 tumors showed the highest incidence of hospital mortality of all groups (P < 0.05).Kaplan-Meier survival analysis showed that OS varied across the three groups as follows:single tumor > 2-3 tumors > 3 + tumors (all P < 0.05).OS rate at 5 years ranged from 24% to 41% in all three groups for the period 2001-2007,and from 35% to 46% for the period 2008-2013.OS was significantly higher during the more recent 6-year period in the entire patient population,those with single tumor,and those with 3 + tumors (all P < 0.05).However,in patients with 2-3 tumors,OS was only slightly higher during the more recent 6-year period (P =0.084).Conclusions Prognosis of three types of HCC was different.Patients with > 3 tumors show the highest hospital mortality and lowest OS after HR.OS has been improving for all three types of HCC at our medical center as a consequence of improvements in surgical technique and perioperative management.

More
广告
  • 浏览245
  • 下载36
中华医学杂志

中华医学杂志

2016年96卷42期

3384-3388页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷